Decision Making about Operability in Non-small Cell Lung Cancer

References

• Rami-Porta K., Wittekind e., Goldstraw P. International Association for the Study of Lung Cancer (IASLC) Staging Committee. Complete resection in lung cancer surgery: proposed definition. Lung Cancer, 2005, 49: 25–33.
   Google Scholar
• Manser K., Wright G., Hart D. et al. Surgery for early stage non-small cell lung cancer. Cochrane Database Syst Rev, 2005 (1): CD004699.
   Google Scholar
• Shields T. W. General Thoracic Surgery, 6th ed. Volume 1, section VII. Pulmonary resections. Lippincott, Williams & Wilkins, Philadelphia, 2005, pp. 411–600.
   Google Scholar
• Van Schil P. Surgery: therapeutic indications. Cancer Radioth, 2007, 11: 47–52.
   Google Scholar
• Reif M., Socinski M., Rivera M. Evidence-based medicine in the treatment of non-small cell lung cancer. Clin Chest Med, 2000, 21: 107–20.
   Google Scholar
• Albain K., Rusch V., Crowley J. et al. Concurrent cisplatin/etopo-side plus chest radiotherapy followed by surgery for stages iiiA (N2) and IIIB non-small cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol, 1995, 13: 1880–92.
   Google Scholar
• Albain K., Swann R., Rusch V. et al. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) versus CT/RT followed by surgical resection for stage IIIA-N2 non-small cell lung cancer: outcomes update of North American Intergroup 0139 (RTOG 9309). J Clin Oncol, 2005, 23 no. 16S: 624s (abstract 7014).
   Google Scholar
• Rusch V., Albain K., Turrisi A. et al. Phase III trial of concurrent chemotherapy and radiotherapy (CT/RT) versus CT/RT followed by surgical resection for stage IIIA-N2 non-small cell lung cancer: outcomes and implications for surgical management in North American Intergroup 0139 (RTOG 9309). Lung Cancer, 2005, 49 (suppl. 2): S15 (abstract 0–035).
   Google Scholar
• Van Meerbeeck J., Kramer G., Van Schil P. et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst, 2007, 99: 442–50.
   Google Scholar
• Van Schil P., Van Meerbeeck J., Kramer G. et al. Morbidity and mortality in the surgery arm of EORTC 08941 trial. Eur Resp J, 2005, 26: 192–7.
   Google Scholar
• Burt M., Wronski M., Arbit E., Galicich J. Resection of brain metastases from non-small cell lung carcinoma: results of therapy. J Thorac Cardiovasc Surg, 1992, 103: 399–410.
   Google Scholar
• Naruke T., Suemasu K., Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg, 1978, 76: 832–9.
   Google Scholar
• Van Schil P., Vankeirsbilck J., Brutel de la Rivière A., van den Bosch J. Long-term survival after bronchial sleeve resection in relation to nodal involvement. Eur J Cardio-thorac Surg, 2000, 17: 196–7.
   Google Scholar
• Graham A., Chan K., Pastorino U., Goldstraw P. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. J Thorac Cardiovasc Surg, 1999, 117: 246–51.
   Google Scholar
• Lardinois D., De Leyn P., Van Schil P. et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg, 2006, 30: 787–92.
   Google Scholar
• Betticher D. C., Hsu Schmitz S. F., Totsch M. et al. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage iiiA pN2 non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol, 2003, 21: 1752–59.
   Google Scholar
• De WaeleM., Hendriks J., Lauwers P. et al. Nodal status at repeat mediastinoscopy determines survival in non-small cell lung cancer with mediastinal nodal involvement, treated by induction therapy. Eur J Cardiothorac Surg, 2006, 29: 240–3.
   Google Scholar
• Kim E. S., Bosquée L. The importance of accurate lymph node staging in early and locally advanced non-small cell lung cancer: an update on available techniques. J Thorac Oncol, 2007, 2 (suppl. 2): S59–S67.
   Google Scholar
• De Leyn P., Stroobants S., De Wever W. et al. Prospective comparative study of integrated positron emission tomography — computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy — proven stage iiiA-N2 non-small cell lung cancer: a Leuven Lung cancer Group Study. J Clin Oncol, 2006, 24: 3333–9.
   Google Scholar
• Van Schil P., De Waele M., Hendriks J., Lauwers P. Remediastinoscopy. J Thorac Oncol, 2007, 2: 365–6.
   Google Scholar
• Stamatis G., Fechner S., Hillejan L. et al. Repeat mediastinoscopy as a restaging procedure. Pneumologie, 2005, 59: 862–6.
   Google Scholar
• Jaklitsch M. T., Gu L., Harpole D. H. et al. Prospective phase II trial of pre-resection thoracoscopic (VATS) restaging following neoadjuvant therapy for iiiA (N2) non-small cell lung cancer: results of CALGB 39803. J Clin Oncol, 2005, 23: 636s (abstract 7065).
   Google Scholar
• Krasnik M., Ernst A., Eberhandt R., Yasufuku K., Herth F. EBUS-TBNA for mediastinal restaging. Eur Resp J, 2006, 28 (suppl. 50): 601–2s (abstract 3541).
   Google Scholar